We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




OCT-Guided Stent Implantation, IVUS, and Angiography-Guided PCI Compared

By MedImaging International staff writers
Posted on 04 Sep 2015
Print article
A medical device vendor has announced the launch of a clinical study to compare intravascular assessments and Percutaneous Coronary Intervention (PCI) during stent implantation, using guidance by Optical Coherence Tomography (OCT), Intravascular Ultrasound (IVUS) or only angiography.

The ILUMIEN III multicenter randomized study is intended to improve the standard of care for cardiovascular patients by using OCT technology to enable clinicians to provide anatomical images of disease morphology, and automatically measure vessel characteristics that are difficult to assess using IVUS or angiography. The measurements are needed for stent selection, stent deployment, and placement, and can decrease the risk of repeated revascularization.

The OCT technique was developed by St. Jude Medical (St. Paul, MN, USA). Clinicians will use St. Jude’s Optis Integrated and ILUMIEN Optis PCI optimization systems for the study. The study will include up to 420 patients from Europe, the US, and Japan.

Clinicians use diagnostic imaging during PCI procedures to decide on the size of the required stent, and increase the minimal stent area (MSA). This revascularization procedure ensures that the stent expands enough during PCI to restore blood flow.

Dr. Mark Carlson, chief medical officer at St. Jude Medical, said, “The launch of ILUMIEN III is an important step in assessing St. Jude Medical’s OCT technology and its ability to improve stent implantation over first generation diagnostic tools. The study builds on important research showing the benefits of OCT imaging in supporting clinical decision making, and we’re excited to have this important trial underway.”

Related Links:

St. Jude Medical



Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Crossover Angiography System
Trinias C16/C12/F12 Unity Smart Edition
Dose Area Product Meter
VacuDAP
Mammography System
MAMMOVISTA B.smart

Print article

Channels

Ultrasound

view channel
Image: Structure of the proposed transparent ultrasound transducer and its optical transmittance (Photo courtesy of POSTECH)

Ultrasensitive Broadband Transparent Ultrasound Transducer Enhances Medical Diagnosis

The ultrasound-photoacoustic dual-modal imaging system combines molecular imaging contrast with ultrasound imaging. It can display molecular and structural details inside the body in real time without... Read more

Nuclear Medicine

view channel
Image: PET/CT of a 60-year-old male patient with clinical suspicion of lung cancer (Photo courtesy of EJNMMI Physics)

Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times

F-18 FDG-PET scans are a way to look inside the body using a special dye, and these scans can be either static or dynamic. Static scans happen 60 minutes after the dye is administered into the body, showing... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The acquisition will expand IBA’s medical imaging quality assurance offering (Photo courtesy of Radcal)

IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering

Ion Beam Applications S.A. (IBA, Louvain-La-Neuve, Belgium), the global leader in particle accelerator technology and a world-leading provider of dosimetry and quality assurance (QA) solutions, has entered... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.